New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients

Author:   Lawrence T Friedhoff MD
Publisher:   Booksurge Publishing
ISBN:  

9781419699610


Pages:   258
Publication Date:   04 June 2009
Format:   Paperback
Availability:   Out of print, replaced by POD   Availability explained
We will order this item for you from a manufatured on demand supplier.

Our Price $60.59 Quantity:  
Add to Cart

Share |

New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients


Add your own review!

Overview

Full Product Details

Author:   Lawrence T Friedhoff MD
Publisher:   Booksurge Publishing
Imprint:   Booksurge Publishing
Dimensions:   Width: 13.30cm , Height: 1.40cm , Length: 20.30cm
Weight:   0.272kg
ISBN:  

9781419699610


ISBN 10:   141969961
Pages:   258
Publication Date:   04 June 2009
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Out of print, replaced by POD   Availability explained
We will order this item for you from a manufatured on demand supplier.

Table of Contents

Reviews

Author Information

During his 30-year career in pharmaceutical research and development, author Lawrence T. Friedhoff, MD, PhD, FACP has amassed an extraordinary record of industry accomplishments, most notably as the head of the teams that chose, developed, and brought two chemical compounds through regulatory approvals around the world. These new drugs are market blockbusters, each used by millions of patients and each generating well over $1 billion annual revenue worldwide. Dr. Friedhoff's first-hand knowledge of pharmaceutical R&D is extensive and comprehensive: he has held management positions at multi-national corporations developing novel drug compounds, small publicly-traded companies manufacturing generic drugs, start-up ventures, and academic-based research teams writing business plans to obtain venture capital. As an R&D head, he held primary responsibility for choosing drug candidates and preparing comprehensive plans for, as well as managing all phases of, their development, always with an eye towards fulfilling FDA (and often, European and Asian) drug requirements. He has also managed post-FDA-approval activities including collecting and analyzing adverse-event information from consumers, fielding inquiries from patients and healthcare providers, and marketing-related scientific studies. Although the press contains numerous reports of disastrous failed clinical trials, during Dr. Friedhoff's career none of the completed pivotal clinical trials for which he was fully responsible ever failed and all of his new drug applications (NDAs) submitted to the FDA were approved. Few industry professionals have been able match his achievements.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

lgn

al

Shopping Cart
Your cart is empty
Shopping cart
Mailing List